Insider Transactions in Q2 2022 at Change Healthcare Inc. (CHNG)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 17
2022
|
Paul Rareshide SVP, Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
826
-1.85%
|
$18,172
$22.96 P/Share
|
|
Jun 17
2022
|
Tracy Byers SVP and GM, Enterprise Imaging |
SELL
Payment of exercise price or tax liability
|
Direct |
882
-0.92%
|
$19,404
$22.96 P/Share
|
|
Jun 17
2022
|
Kriten Joshi Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,422
-0.98%
|
$119,284
$22.96 P/Share
|
|
Jun 17
2022
|
Steven B. Martin EVP, Enterprise Technology |
SELL
Payment of exercise price or tax liability
|
Direct |
5,399
-1.13%
|
$118,778
$22.96 P/Share
|
|
Jun 01
2022
|
Linda Whitley Taylor EVP & Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
29,432
+12.69%
|
-
|
|
Jun 01
2022
|
August Calhoun Officer |
BUY
Grant, award, or other acquisition
|
Direct |
34,626
+11.74%
|
-
|
|
Jun 01
2022
|
Loretta A. Cecil EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
30,817
+13.06%
|
-
|
|
Jun 01
2022
|
Fredrik J Eliasson EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
69,252
+10.41%
|
-
|
|
Jun 01
2022
|
Neil E. De Crescenzo President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
199,099
+12.27%
|
-
|
|
Jun 01
2022
|
Thomas Mcenery EVP & Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,817
+10.68%
|
-
|
|
Jun 01
2022
|
Thomas Laur Officer |
BUY
Grant, award, or other acquisition
|
Direct |
34,626
+13.06%
|
-
|
|
Jun 01
2022
|
Kriten Joshi Officer |
BUY
Grant, award, or other acquisition
|
Direct |
34,626
+5.89%
|
-
|
|
Jun 01
2022
|
Paul Rareshide SVP, Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct |
7,617
+14.54%
|
-
|
|
Apr 25
2022
|
Phillip W. Roe Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,658
+15.83%
|
-
|
|
Apr 25
2022
|
Robert Zollars Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,658
+15.83%
|
-
|
|
Apr 25
2022
|
Bansi Nagji Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,658
+16.32%
|
-
|
|
Apr 25
2022
|
Philip M Pead Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,658
+6.94%
|
-
|
|
Apr 25
2022
|
Howard L Lance Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,658
+3.27%
|
-
|
|
Apr 25
2022
|
Nella Domenici Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,658
+20.73%
|
-
|
|
Apr 25
2022
|
Diana Mckenzie Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,658
+15.83%
|
-
|
|
Apr 15
2022
|
Neil E. De Crescenzo President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
376,773
+23.52%
|
-
|
|
Apr 15
2022
|
Fredrik J Eliasson EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
190,159
+26.53%
|
-
|
|
Apr 15
2022
|
Thomas Laur Officer |
BUY
Grant, award, or other acquisition
|
Direct |
73,138
+27.18%
|
-
|
|
Apr 15
2022
|
Kriten Joshi Officer |
BUY
Grant, award, or other acquisition
|
Direct |
246,010
+32.18%
|
-
|
|
Apr 15
2022
|
August Calhoun Officer |
BUY
Grant, award, or other acquisition
|
Direct |
105,274
+31.8%
|
-
|
|
Apr 15
2022
|
Steven B. Martin EVP, Enterprise Technology |
BUY
Grant, award, or other acquisition
|
Direct |
243,794
+33.84%
|
-
|
|
Apr 15
2022
|
Loretta A. Cecil EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
73,138
+29.56%
|
-
|
|
Apr 15
2022
|
Linda Whitley Taylor EVP & Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
73,138
+29.71%
|
-
|
|
Apr 15
2022
|
Thomas Mcenery EVP & Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
73,138
+24.38%
|
-
|
|
Apr 15
2022
|
Paul Rareshide SVP, Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct |
11,081
+22.98%
|
-
|
|
Apr 13
2022
|
Steven B. Martin EVP, Enterprise Technology |
SELL
Payment of exercise price or tax liability
|
Direct |
10,899
-4.47%
|
$250,677
$23.77 P/Share
|
|
Apr 01
2022
|
Paul Rareshide SVP, Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
1,324
-4.83%
|
$27,804
$21.8 P/Share
|
|
Apr 01
2022
|
Steven B. Martin EVP, Enterprise Technology |
SELL
Payment of exercise price or tax liability
|
Direct |
3,653
-1.48%
|
$76,713
$21.8 P/Share
|
|
Apr 01
2022
|
Kriten Joshi Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,438
-1.6%
|
$93,198
$21.8 P/Share
|